ivarmacitinib
reistone
['ivarmacitinib', 'derm']
late breaking data from #aad23 showed that treatment with ivarmacitinib (8 mg or 4 mg) was well-tolerated/effective in patients aged 12 and over with moderate-to-severe atopic dermatitis. check out the data here: #aad2023 #eczema
Clinical News for Connected Physicians. Everything you need to enhance your clinical approach to improving patient care.